Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 4-[(3R)-3-aminopyrrolidin-1-yl]-6-propan-2-ylpyrimidin-2-amine | 1046447-90-8 | MFCD28502028 | 99.7% | 221.16404563 g·mol⁻¹ | C11H19N5 | 1 ML
SDP

Catalog No. 5000212078
Encompass_Preferred

JNJ-39758979 is a selective histamine H4 receptor antagonist supplied for research use. It is available as a ready-to-use 10 mM solution in DMSO (1 mL) and as solid material in multiple milligram quantities. The compound is used in receptor pharmacology and in vitro assays to evaluate H4-mediated activity.

  • Selective histamine H4 receptor antagonist suitable for pharmacology studies.
  • Provided as a 10 mM solution in DMSO (1 mL) and as solid in multiple mg sizes.
  • High purity, 99.7%.
  • CAS number 1046447-90-8 and molecular formula C11H19N5.
  • Exact molecular weight 221.164 g·mol⁻¹.

Catalog No. 50-002-12078 Supplier Medchemexpress LLC Supplier No. HY10118910MM 1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

JNJ-39758979 is a selective histamine H4 receptor antagonist supplied for research use. It is available as a ready-to-use 10 mM solution in DMSO (1 mL) and as solid material in multiple milligram quantities. The compound is used in receptor pharmacology and in vitro assays to evaluate H4-mediated activity.

  • Selective histamine H4 receptor antagonist suitable for pharmacology studies.
  • Provided as a 10 mM solution in DMSO (1 mL) and as solid in multiple mg sizes.
  • High purity, 99.7%.
  • CAS number 1046447-90-8 and molecular formula C11H19N5.
  • Exact molecular weight 221.164 g·mol⁻¹.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.